251 related articles for article (PubMed ID: 17272400)
21. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 ameliorates obesity-related insulin resistance.
Shao S; Zhang X; Zhang M
Biochem Biophys Res Commun; 2016 Sep; 478(1):474-480. PubMed ID: 27268236
[TBL] [Abstract][Full Text] [Related]
22. Preliminary report: pharmacologic 11beta-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet.
Berthiaume M; Laplante M; Festuccia WT; Berger JP; Thieringer R; Deshaies Y
Metabolism; 2010 Jan; 59(1):114-7. PubMed ID: 19766266
[TBL] [Abstract][Full Text] [Related]
23. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
24. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
Harno E; Cottrell EC; Yu A; DeSchoolmeester J; Gutierrez PM; Denn M; Swales JG; Goldberg FW; Bohlooly-Y M; Andersén H; Wild MJ; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Dec; 154(12):4580-93. PubMed ID: 24169553
[TBL] [Abstract][Full Text] [Related]
25. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
Wang L; Liu J; Zhang A; Cheng P; Zhang X; Lv S; Wu L; Yu J; Di W; Zha J; Kong X; Qi H; Zhong Y; Ding G
PLoS One; 2012; 7(7):e40056. PubMed ID: 22768329
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
[TBL] [Abstract][Full Text] [Related]
27. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Nuotio-Antar AM; Hachey DL; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
[TBL] [Abstract][Full Text] [Related]
28. PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.
Laplante M; Sell H; MacNaul KL; Richard D; Berger JP; Deshaies Y
Diabetes; 2003 Feb; 52(2):291-9. PubMed ID: 12540599
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
[TBL] [Abstract][Full Text] [Related]
30. Fructose and stress induce opposite effects on lipid metabolism in the visceral adipose tissue of adult female rats through glucocorticoid action.
Kovačević S; Nestorov J; Matić G; Elaković I
Eur J Nutr; 2017 Sep; 56(6):2115-2128. PubMed ID: 27324140
[TBL] [Abstract][Full Text] [Related]
31. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
Li X; Lindquist S; Chen R; Myrnäs T; Angsten G; Olsson T; Hernell O
Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
[TBL] [Abstract][Full Text] [Related]
32. A post-weaning fish oil dietary intervention reverses adverse metabolic outcomes and 11β-hydroxysteroid dehydrogenase type 1 expression in postnatal overfed rats.
Dai Y; Yang F; Zhou N; Sha L; Zhou S; Wang J; Li X
Br J Nutr; 2016 Nov; 116(9):1519-1529. PubMed ID: 27819216
[TBL] [Abstract][Full Text] [Related]
33. Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats.
Sakamuri VP; Ananthathmakula P; Veettil GN; Ayyalasomayajula V
Nutr J; 2011 Jun; 10():70. PubMed ID: 21696642
[TBL] [Abstract][Full Text] [Related]
34. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
35. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
36. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
37. Reduced SCD1 activity alters markers of fatty acid reesterification, glyceroneogenesis, and lipolysis in murine white adipose tissue and 3T3-L1 adipocytes.
Dragos SM; Bergeron KF; Desmarais F; Suitor K; Wright DC; Mounier C; Mutch DM
Am J Physiol Cell Physiol; 2017 Sep; 313(3):C295-C304. PubMed ID: 28659287
[TBL] [Abstract][Full Text] [Related]
38. Additive action of 11beta-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats.
Berthiaume M; Laplante M; Festuccia WT; Berger JP; Thieringer R; Deshaies Y
Int J Obes (Lond); 2009 May; 33(5):601-4. PubMed ID: 19223847
[TBL] [Abstract][Full Text] [Related]
39. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
[TBL] [Abstract][Full Text] [Related]
40. Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
Metabolism; 2012 Jun; 61(6):823-35. PubMed ID: 22209663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
